K-numberK251362
Device namePediFlex™ Flexible Nail System
ApplicantOrthoPediatrics Corp.
Product codeHTY
Device classClass II
Decision dateJun 24, 2025
DecisionSubstantially Equivalent
Regulation888.3040
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The PediFlex™ Flexible Nail System is an intramedullary nail fixation device made from 316L stainless steel or titanium alloy, designed to repair diaphyseal fractures of long bones with narrow medullary canals or where implant flexibility is needed. It is indicated for upper extremity fractures in all patients and lower extremity fractures in pediatric or small stature patients, with the flexibility allowing insertion without disturbing growth plates.

Technological characteristics

The subject device and predicate share identical intended use, patient population, principles of operation, and fundamental technological characteristics. Differences exist in sterilization processing, packaging design, shelf life labeling, and addition of MR conditional labeling, all supported by validation testing. Material options (316L stainless steel and titanium alloy) and component sizes remain functionally equivalent to the predicate.

Test standards cited

Sterilization and cleaning validation per AAMI ST72, AAMI ST98, ASTM F3127, ISO 11137-1/2, ISO 11737-1/2/3, and ISO 19227. Package design and shelf life validation per ASTM D4332, D4169, F2096, F2203, F88, F1886, ISO 11607-1/2, and ISO 15415/15416. MR safety evaluation per ASTM F2052, F2213, F2182, F2119, and FDA MR guidance (October 2023). Usability validation per ISO 11607-1 and IEC-62366-1.

Substantial equivalence argument

The subject device is substantially equivalent because it maintains the same intended use, patient population, design principles, and core technological characteristics as the predicate device (K201838). Although sterilization, packaging, shelf life, and MR conditional labeling differ from the predicate, these differences are non-fundamental and supported by comprehensive validation testing demonstrating no new safety or effectiveness concerns. Biocompatibility was assessed and found acceptable given the identical materials and modified processing flow.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →